Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Study to Compare the Safety and Efficacy of IPX203 With Immediate-Release Carbidopa-Levodopa in Parkinson's Disease Patients With Motor Fluctuations

NCT03670953 is registered in ClinicalTrials.gov with Impax Laboratories, LLC as lead sponsor.

NCT NCT03670953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03670953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Study to Compare the Safety and Efficacy of IPX203 With Immediate-Release Carbidopa-Levodopa in Parkinson's Disease Patients With Motor Fluctuations
Lead sponsor
Impax Laboratories, LLC
Phase
Phase 3
Overall status
Completed
Start date
November 6, 2018
Completion date
June 15, 2021
Enrollment
630 (actual)
Sites
108

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease (disorder)